Proposal on capital reduction from the company’s board of directors

The board of directors of Equinor ASA (OSE: EQNR, NYSE: EQNR) has today decided to propose to the general meeting of the company that the company’s share capital is reduced through cancellation of own shares and redemption of shares belonging to the Norwegian State.
The proposal is made as a result of the company having acquired own shares pursuant to the authorization for share buy-back granted by the annual general meeting of the company in May 2024.
The proposal entails that the company's share capital shall be reduced by NOK 589,934,295 from NOK 6,981,953,075.00 to NOK 6,392,018,780.00, through cancellation and redemption of a total of 235,973,718 shares. Notice of the general meeting of the company which will attend to the board’s proposal will be announced separately at a later stage.
This information is subject to the disclosure requirements pursuant to Euronext Oslo Børs Rulebook II section 4.2.4 and Section 5-12 of the Norwegian Securities Trading Act.
Contact persons:
Investor relations:
Bård Glad Pedersen, Senior vice president Investor Relations,
+47 918 01 791
Media relations:
Sissel Rinde, Vice president Media Relations,
+47 412 60 584
Latest news
Equinor first quarter 2025 results
Equinor delivered adjusted operating income* of USD 8.65 billion and USD 2.25 billion after tax in the first quarter of 2025. Equinor reported net operating income of USD 8.87 billion and net income at USD 2.63 billion. Adjusted net income* was USD 1.79 billion, leading to adjusted earnings per share* of USD 0.66.
Equinor to commence second tranche of the 2025 share buy-back programme
Equinor (OSE: EQNR, NYSE: EQNR) will after the annual general meeting 14 May 2025 commence the second tranche of up to USD 1,265 million of the share buy-back programme for 2025, as announced in relation with the first quarter results 30 April 2025.
Key information relating to cash dividend for first quarter 2025
Key information relating to the cash dividend to be paid by Equinor for first quarter 2025.